UChicago Medicine
UChicago Medicine
Publishes a two-year cost comparison of bariatric surgery against GLP-1 therapy
- Membership
- Not published
- Medication
- Not published
Advertising disclosure: We earn commissions from some of the products we link to. It never changes our scores or what we publish. Read the full disclosure
Duke Health
Duke Health offers weight management and bariatric services, and publishes clear material distinguishing which GLP-1s are approved for type 2 diabetes versus weight management — a distinction most commercial sites blur.
Sources captured · researched by Tom
As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.
Duke Health publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers
These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.
Captured . Pages change — check the current version before relying on anything here.
UChicago Medicine
Publishes a two-year cost comparison of bariatric surgery against GLP-1 therapy
Stanford Health Care
Academic medical centre with a multispecialty team including bariatric surgeons
Johns Hopkins Medicine
Academic medical centre stating plainly that GLP-1s are usually not covered for weight loss